FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 253 filers reported holding FATE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.84 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $300,302 | -10.9% | 141,652 | +100.0% | 0.00% | – |
| Q2 2023 | $337,132 | -16.5% | 70,826 | 0.0% | 0.00% | – |
| Q1 2023 | $403,708 | -43.5% | 70,826 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $714,634 | -64.3% | 70,826 | -20.9% | 0.00% | -66.7% |
| Q3 2022 | $2,000,000 | -28.1% | 89,526 | -20.2% | 0.00% | 0.0% |
| Q2 2022 | $2,781,000 | -39.0% | 112,240 | -4.5% | 0.00% | -25.0% |
| Q1 2022 | $4,559,000 | -27.0% | 117,580 | +10.2% | 0.00% | -20.0% |
| Q4 2021 | $6,242,000 | -1.3% | 106,681 | 0.0% | 0.01% | -28.6% |
| Q3 2021 | $6,323,000 | -13.0% | 106,681 | +21.5% | 0.01% | 0.0% |
| Q2 2021 | $7,271,000 | -0.5% | 87,810 | -0.9% | 0.01% | -12.5% |
| Q1 2021 | $7,306,000 | -9.9% | 88,610 | -0.6% | 0.01% | -20.0% |
| Q4 2020 | $8,109,000 | +247.0% | 89,180 | +52.5% | 0.01% | +233.3% |
| Q3 2020 | $2,337,000 | +98.1% | 58,480 | +70.1% | 0.00% | +50.0% |
| Q2 2020 | $1,180,000 | +70.8% | 34,380 | +10.5% | 0.00% | +100.0% |
| Q1 2020 | $691,000 | +0.9% | 31,109 | -11.1% | 0.00% | 0.0% |
| Q4 2019 | $685,000 | +4.7% | 35,009 | -16.9% | 0.00% | 0.0% |
| Q3 2019 | $654,000 | -23.1% | 42,109 | +0.5% | 0.00% | 0.0% |
| Q2 2019 | $851,000 | +20.5% | 41,909 | +4.2% | 0.00% | 0.0% |
| Q1 2019 | $706,000 | +24.5% | 40,209 | -9.0% | 0.00% | 0.0% |
| Q4 2018 | $567,000 | -15.5% | 44,209 | +7.3% | 0.00% | 0.0% |
| Q3 2018 | $671,000 | +67.3% | 41,185 | +16.3% | 0.00% | 0.0% |
| Q2 2018 | $401,000 | -1.2% | 35,400 | -14.9% | 0.00% | 0.0% |
| Q1 2018 | $406,000 | +256.1% | 41,600 | +122.8% | 0.00% | – |
| Q4 2017 | $114,000 | – | 18,668 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $51,820,000 | 67.63% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $307,258,000 | 39.62% |
| Darwin Global Management, Ltd. | 952,847 | $86,642,000 | 24.18% |
| Redmile Group, LLC | 12,629,737 | $1,148,422,000 | 13.91% |
| DAFNA Capital Management LLC | 334,360 | $30,403,000 | 9.05% |
| Casdin Capital, LLC | 3,050,000 | $277,337,000 | 8.22% |
| Grosvenor Holdings, L.L.C. | 1,459,517 | $132,714,000 | 7.23% |
| Copernicus Capital Management, LLC | 3,240 | $295,000 | 4.60% |
| Eversept Partners, LP | 399,499 | $36,326,444 | 4.26% |
| Ally Bridge Group (NY) LLC | 260,000 | $23,642,000 | 4.05% |